Skip to main content
. 2015 Dec 28;12:S111–S198. doi: 10.1111/j.1470-9465.2006.12_4_1427.x
Tigecycline
% inhibited at MIC
Orqanism (#) MIC50 MIC90 ≤0.25 0.5 1 2 4
Acinetobacter spp. (921) 0.25 1 50 66.8 91 98.4 99.9

E. faecalis/faecium (1,034) 0.06 0.12 99.6 100

VREa (232) 0.06 0.12 99.6 100

EC, KO, KPb (3,506) 0.25 1 64.5 86.9 94.7 97.6 99.7

ESBLc (166) 1 2 26.5 48.8 83.1 93.4 98.8

H. influenzae (860) 0.12 0.25 94.7 97.7 99.9 100

P. aeruginosa (1,338) 8 >16 0.7 1.3 2.5 5 16.9

S. aureus (MS) (826) 0.12 0.12 99.6 100

S. aureus (MR) (870) 0.12 0.25 99.6 100

S. pneumoniae (972) 0.06 0.5 83 93.7 99.9 100
a

VRE, E. faecium/faecalis phenotypes

b

EC, E. coli; KO, K. oxytoca; KP, K. pneumoniae

c

ESBL, producing EC, KO and KPM